Cyrano Therapeutics logo

Cyrano Therapeutics Funding & Investors

Cyrano Therapeutics is developing an intranasal product designed to restore function in patients with a chronic loss of taste and smell.

cyranotherapeutics.com

Total Amount Raised: $21,800,000

Cyrano Therapeutics Funding Rounds

  • Series B

    $9,000,000

    Series B Investors

    DeepWork Capital
    Remiges Ventures
    Lumira Capital Investment Management
  • Series A

    $12,800,000

    Series A Investors

    Lumira Capital Investment Management
    Remiges Ventures
Funding info provided by Diffbot.